- 16 ноября 2013, 20:01
- Forbes.com: News
These are the best and worst-performing medical and biotech stocks from from Nov. 8 to Nov. 15. This screen includes biotechnology and medical companies traded on the New York Stock Exchange, the Nasdaq or the American Stock Exchange that had market capitalizations of more than $300 million as of a week ago. The data come from Interactive Data and Thomson Reuters Fundamentals via FactSet Research Systems. During this time, the American Stock Exchange’s Biotechnology index rose 4.4%.